Background: Childhood cancer survivors can have a high burden of chronic conditions related to cancer treatment, some of which are debilitating or potentially life-threatening. Much remains to be learned about late effects in bone and soft tissue sarcoma survivors. 
treatable stage. 4 The majority of healthcare programs designed for bone and soft tissue sarcoma patients revolve around improving physical function, while other areas such as psychological and social functioning are often poorly addressed. 5 In addition, some larger oncology programs have late effect clinics that provide cancer survivors with preventive care, close follow-up, and screening to improve the overall health. However, these services are rare, especially for patients living outside of major cities, and underutilized due to lack of insurance, lack of adequate financial resources, work and family obligations, and inability to navigate the healthcare system. 6 As part of an earlier study, our team found that long-term survivors of bone and soft tissue sarcoma are hospitalized at a rate 2.55 and 1.82 times, respectively, than that of similar-aged comparisons without cancer 7 using data from the statewide Utah Population Database (UPDB) and Utah Cancer Registry (UCR). Here, we extend our earlier analyses to evaluate differences in hospitalization and hospital morbidity for these patients and to better understand the impact of risk factors (e.g., sex, treatment) on hospitalizations. We hypothesized that bone and soft tissue sarcoma survivors who received chemotherapy for the treatment of their original cancer were at an increased risk of hospitalization than survivors not receiving chemotherapy. Reasons for hospitalization among these patients were explored to identify potential areas for improvement in patient care.
METHODS

Data access
The UCR, a National Cancer Institute Surveillance Epidemiology and End Results (SEER) registry of statewide cancer records, was used to identify bone and soft tissue sarcoma survivors. Demographic information and vital records (birth and death certificates) were obtained from the University of Utah's Pedigree and Population Resource, which houses the UPDB. 8, 9 Records from the UPDB are linked to statewide resources, including the UCR and Utah Department of Health (DOH). 
Participants
Children and adolescents (ages <21 years at diagnosis) diagnosed with bone or soft tissue sarcoma were identified using the UCR from 1973 to 2007. Similar to one of our previous papers, 7 a comparison sample without a history of cancer and matched by sex and age was also selected from the UPDB. Bone and soft tissue sarcoma survivors were classified based on the International Classification of Childhood Cancers. Due to treatment similarities, the extra-osseous Ewing sarcoma survivors were aggregated under the bone tumor group. As our goal was to understand late effects after therapy, we defined "survivors" as patients who were alive 5 or more years from their original diagnosis date and limited analyses to this group.
Measures
Hospitalization outcomes
Hospitalization discharge data were available from 1996 to 2012.
Using discharge records, the total number of inpatient hospitalizations was calculated for the bone and soft tissue sarcoma survivors and the comparison group, counting hospitalizations taking place 5 years after diagnosis and later. Hospitalizations for pregnancy or delivery based on International Classification of Disease Version 9 (ICD-9) codes were excluded. Hospital diagnoses were determined using the principal ICD-9 diagnosis code for that admission. These codes are grouped by ICD-9 chapter, generally equivalent to organ systems or disease process, to classify the type of late morbidity. The ICD-9 chapter "injury" includes complications of surgical and medical treatment (i.e., postoperative infections and mechanical complications of internal orthopedic devices).
Cancer-related measures
The UCR provided diagnosis, age at diagnosis, year of diagnosis, age at last follow-up, and first course of treatment received for their original cancer (e.g., receipt of surgery, chemotherapy, or radiation). "Systemic treatment" included any receipt of chemotherapy, whether alone or in combination with other modalities. "Local treatment" was defined by any treatment modality in which chemotherapy was not utilized (i.e., radiation and/or surgery).
Other variables
Demographic information such as sex, year of birth, age at last followup, race/ethnicity, and county of birth was obtained from birth certificate data from the UPDB and records from the UCR. The vast majority (>85%) of Utah residents are Caucasians with European ancestry.
As a result, race/ethnicity was grouped as non-Hispanic White versus
Other. Rural residence at diagnosis/index date was defined as living in a county with less than 75% of the population in an urban area (population >2,500). the survivor and comparison group are statistically compared by using the log-rank test. Hypothesis tests were two-tailed and significance level was set at P <0.05. All analyses were performed using SAS 9.4.
Statistical analyses
Complete hospitalization data were available starting in 1996, so hospitalizations are not captured for those patients diagnosed from 1973 to 1990 until this date. To address this issue, two diagnosis year subgroups were created (1973-1990 and 1991-2007) , which allowed for evaluation of hospitalization differences between the two groups starting at least 5 years after diagnosis. In survivor-only models, differences by demographics (age at diagnosis, sex) and by systemic treatment versus local were examined by fitting the models for these subgroups adjusting for time since diagnosis. Frequency of different primary ICD-9 codes for hospitalization were tallied to find the most common cause for hospitalization. Multivariable Cox regression models were estimated to compare the time to first hospitalization for each ICD-9 code between survivors and the comparison group. In Table 3 , the primary diagnosis of the first hospitalization during follow-up showed that neoplasms were the most common admitting diagnosis with an HR of 11. Two other studies demonstrated similar results in which neoplasms and injury were one of the most common reasons for hospitalizations among bone and soft tissue sarcoma survivors. 11, 12 There are some limitations to this study. 
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